Alexion Pharmaceuticals,Inc.

About Alexion Pharmaceuticals,Inc.

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the treatment disease, including hematologic and neurologic diseases, cancer and autoimmune disorders. The Company has one marketed product, Soliris (eculizumab), which is a therapy approved for – more... 

Claim this company page
Headquarters
Cheshire Connecticut, United States
Revenue
1bn to 5bn (EUR)
Employees
501 to 1,000
Industry
Links
Alexion Pharmaceuticals,Inc. website